monthly healthcare review april 2017 - bioenterprise...abg sundal collier asa, arctic securities,...
TRANSCRIPT
Monthly Healthcare Review
April 2017
Company NameLast Financing
DateHQ Location Description
Last
Financing
Size
(Millions)
Lead Manager
Zymeworks (ZYME) 28-Apr-17
Vancouver,
Canada
Developer of antibodies and protein therapeutics for the treatment of cancer, autoimmune
and inflammatory diseases. 58.5
Barclays Capital,
Citigroup Global
Markets Canada,
Wells Fargo
Securities
Tocagen (TOCA) 12-Apr-17 San Diego, CA
Developer of cancer-selective gene therapies designed to activate a patient's immune system
to fight against their own cancer from within. 0.85
Evercore Group,
Leerink Partners,
Stifel Nicolaus &
Company
BerGenBio (BGBIO) 7-Apr-17
Bergen,
Norway Developer of small molecule cancer drugs designed to treat aggressive cancers. 47.08
ABG Sundal Collier
ASA, Arctic
Securities, DNB
Markets
The following table includes the medical devices, biotechnology, pharmaceuticals, and healthcare IPO pricings, filings and withdrawals announced over the previous month.
IPOs
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 1
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Epic Sciences 28-Apr-17 San Diego, CA Later Stage VC
Developer of diagnostic tests designed to enable the rapid and non-
invasive detection of genetic and molecular changes in cancer
throughout a patient's journey. 0.40
Hermed Capital, Altos
Capital Partners,
Domain Associates,
Genomic Health,
Pagoda Asset
Management, Reach
Tone, RMI Partners,
Sabby Capital, VI
Ventures
Congenica 27-Apr-17
Cambridge, United
Kingdom Early Stage VC
Developer of a clinical genome analysis platform designed to process
genome wide data sets to detect mutations by filtering clinically
relevant variants and deep clinical phenotyping. 9.87
Cambridge Innovation
Capital, Amadeus
Capital Partners,
Parkwalk Advisors, BGI
Genomics, Healthlink
Capital and Future
Planet Capital
BlueStar HonorCare 27-Apr-17 Rockville, MD Angel
Provider of medical alert systems, health monitoring devices and
personal safety devices that enable seniors, elders and veterans to stay
connected and allow family members to monitor their health. 1.33 Undisclosed Investors
Avedro 27-Apr-17 Waltham, MA Later Stage VC
Operator of a pharmaceutical and medical device company intended
to advance the treatment of eye conditions, such as keratoconus and
corneal ectasia, through the continued innovation of its cross-linking
technology and family of Riboflavin products. 0.42
HealthQuest Capital,
OrbiMed, InterWest
Healthcare Partners
One Stone Technology 26-Apr-17 Cazenovia, NY Angel
Developer of a patient engagement software designed for activating
patients through personalized messaging. 0.25 Undisclosed Investors
Medicortex 26-Apr-17 Turku, Finland Angel
Developer of biomarker diagnostics that evaluate the extent and
severity of traumatic brain injury. 0.21 Invesdor
Learning Health 26-Apr-17 Tiburon, CA Angel
Provider of a healthcare management platform that allows users to
access prescribed treatments. 0.58 Undisclosed Investors
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 2
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Jump Technologies 26-Apr-17 Eagan, MN
PE Growth/
Expansion
Developer of cloud-based mobile supply chain software intended to
improve the way supplies are managed from demand through use and
replenishment. 3.50
Black Granite Capital,
Undisclosed Investors
Evidation Health 26-Apr-17 San Mateo, CA Early Stage VC
Developer of a technology and services platform designed to
accelerate and enhance outcomes research through virtualized
pragmatic trials. 0.10
Sanofi Genzyme
BioVentures, GE
Ventures, B Capital
Group
Arsanis 26-Apr-17 Waltham, MA Later Stage VC
Developer of monoclonal antibodies designed to prevent and treat
serious infectious diseases by targeting specific pathogens or their
virulence mechanisms to avoid pathogenic processes. 45.50
Bill Melinda Gates
Foundation, GV,
Alexandria Real Estate
Equities, OrbiMed,
Polaris Partners, SV
Health Investors,
NeoMed Management,
EMBL Ventures, Anna
Maria & Stephen Kellen
Foundation
Allotrope Medical 26-Apr-17 Houston, TX Seed Round
Developer of a surgical device designed to identify and localize
ureters. 0.35
Houston Health
Ventures, Houston
Angel Network
AIdoc 26-Apr-17 Tel Aviv, Israel Early Stage VC
Developer of an artificial intelligence and deep learning platform that
analyzes medical images and patient's clinical information in order to
detect critical abnormalities, as well as integrates all relevant diagnostic
and clinical data into a comprehensive patient view. 0.07
TLV Partners, Magma
Ventures, Emerge
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 3
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Zebra Medical Vision 25-Apr-17
Kibbutz Shefayim,
Israel Early Stage VC
Provider of a medical imaging research and analytics platform
designed to provide automated, accurate and timely medical image
diagnosis. Undisclosed
Intermountain
Healthcare, Dolby
Family Ventures,
OurCrowd First,
OurCrowd, Marc
Benioff, Khosla
Ventures
Two Pore Guys 25-Apr-17 Santa Cruz, CA Later Stage VC
Developer of a digital, hand-held and single-molecule biosensor
designed to detect virtually any kind of molecule with very high
sensitivity. 24.50 Khosla Ventures
Top Doctors 25-Apr-17 Barcelona, Spain Later Stage VC
Developer of a medical app designed to find world-class doctors and
medical centers. 3.21
Addventure,
Undisclosed Investors
Science 37 25-Apr-17 Los Angeles, CA Later Stage VC
Developer of a cloud-based, patient-centric mobile research platform
that connects participants in clinical trials. 0.29
Glynn Capital
Management, GV,
Amgen Ventures, Lux
Capital, Redmile Group,
DRX Capital, Sanofi
Ventures
Respira Therapeutics 25-Apr-17 Albuquerque, NM Later Stage VC
Developer of inhaled pharmaceutical products that deliver dry powder
drug products to the lung more effectively. 9.11
United Therapeutics,
Cottonwood
Technology Fund, Sun
Mountain Capital,
Undisclosed Investors
HealthVerity 25-Apr-17 Philadelphia, PA Early Stage VC
Provider of healthcare data and patient informatics designed to offer
enhanced data discovery and distribution. 0.10
Flare Capital Partners,
Greycroft Partners,
Foresite Capital Partners
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 4
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Forge Therapeutics 25-Apr-17 San Diego, CA Early Stage VC
Developer of antibacterial therapeutics created to treat multi-drug
resistant bacteria. 0.15
SigmaBleyzer, Evotec,
Alexandria Venture
Investments, MP
Healthcare Venture
Management, Red Apple
Group, WS Investments
EpimAb
Biotherapeutics 25-Apr-17
Warmsroth,
Germany Early Stage VC
Provider of biopharmaceutical research and development services
intended to generate novel bi-specific antibody therapeutics. 0.25
Oriza Seed Capital,
Decheng Capital, 3E
Bioventures Capital,
Trend Investment
Group
Doc Halo 25-Apr-17 Cincinnati, OH Later Stage VC
Developer of a clinical communication platform intended to
transform patient care by streamlining real-time communication
among physicians, nurses and staff. 0.11
Bain Capital Ventures,
Refinery Ventures
Dance Biopharm 25-Apr-17 Brisbane, CA
PE Growth/
Expansion
Developer of a pocket-sized inhaler device and insulin container
designed to control prandial blood sugar in adults with diabetes
without the need for injections. 1.46
Aegis Capital Group,
Undisclosed Investors
Circle Pharma 25-Apr-17
South San
Francisco, CA Early Stage VC
Developer of potent, specific and cell-permeable macrocyclic peptides
against important therapeutic targets. 6.50
Mission Bay Capital,
Pfizer Venture
Investments,
ShangPharma
Investment, WI Harper
Group, Elements
Partners, Whitesun
Healthcare Ventures,
LifeForce Ventures and
other undisclosed
investors
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 5
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
ChromaCode 25-Apr-17 Carlsbad, CA Early Stage VC
Developer of biotechnological software, reagents and assay products
designed to increase real time PCR instrument's multiplexing. 12.02
New Enterprise
Associates, Domain
Associates and Okapi
Ventures
BluPanda 25-Apr-17 Pittsburgh, PA Angel Provider of robotics management services for the healthcare industry. 2.92 Undisclosed Investors
Babylon Health 25-Apr-17
London, United
Kingdom Early Stage VC
Developer of a digital healthcare consultation application allowing
users to make doctor appointments, access clinical records and
monitor health. 0.60
Hoxton Ventures
Kinnevik and Vostok
New Ventures, Nassef
Sawiris, NNS Holdings,
Undisclosed Investors
Anagin 25-Apr-17 Indianapolis, IN Early Stage VC Developer of a therapy for post traumatic distress syndrome. 3.05 Undisclosed Investors
AltheaDx 25-Apr-17 San Diego, CA Later Stage VC Developer of a pharmacogenetics product testing portfolio. 0.27 Undisclosed Investors
Triggr Health 24-Apr-17 Chicago, IL Early Stage VC
Developer of a predictive system of care designed to help in addiction
recovery with the help of a machine learning algorithm that measures
a person's sleep history, call logs, texting history and general
smartphone usage. 4.20 Drive Capital
Sienna
Biopharmaceuticals 24-Apr-17
Westlake Village,
CA Later Stage VC
Provider of medical dermatology and aesthetics treatment therapies
designed to focus on developing safe and effective targeted therapies
to treat inflammatory skin conditions. 0.40
ARCH Venture
Partners, VenVest
Capital, Partner Fund
Management, Altitude
Life Science Ventures,
David Pyott, Fidelity
Management &
Research
Osteonovus 24-Apr-17 Toledo, OH Angel
Developer of a synthetic bone graft to fill bone gaps and voids in the
skeletal system during orthopedic surgery. 2.50 Undisclosed Investors
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 6
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
NanoPharmaceuticals 24-Apr-17 Rensselaer, NY Angel
Developer of pharmaceutical products for a range of health issues,
including macular degeneration, ocular disorders, solid tumors,
hematologic malignancies, arthritis and dermatological conditions. 0.02 Undisclosed Investors
MPIRICA Health 24-Apr-17 Bellevue, WA Early Stage VC
Provider of a cloud-based surgery quality scores platform that enables
patients and payers to avoid surgery risks and costs by directly
connecting patients to high-quality providers. 4.60
OurCrowd, Undisclosed
Investors
KSK Diagnostics 24-Apr-17 Hamburg, Germany Early Stage VC
Developer of molecular point-of-care diagnostic assays designed to
diagnose infectious diseases and cancer. Undisclosed
Innovationsstarter, High
Tech Gründerfonds
SteadyMed Therapeutics
(STDY) 23-Apr-17 San Ramon, CA PIPE
Developer of specialty medical devices designed to deliver injectable
therapeutic drugs. 0.30
Adage Capital
Management, OrbiMed
Deerfield Management,
Kingdon Capital
Management, Ari
Steimatzky, Undisclosed
Investors
SynGen 21-Apr-17 Sacramento, CA Later Stage VC
Developer of single-use disposable cartridges to capture stem and
progenitor cells from peripheral and umbilical cord blood, bone
marrow and adipose tissue. 0.04 Undisclosed Investors
Lyric Pharmaceuticals 21-Apr-17
South San
Francisco, CA Early Stage VC Developer of gastrointestinal therapeutics. 26.79
RiverVest Venture
Partners Sante Ventures,
Third Point Ventures,
Aperture Venture
Partners, Undisclosed
Investors
Healthie 21-Apr-17 Lewes, DE Seed Round
Provider of a cloud-based electronic health records platform for
dietitians. 1.28
Dorm Room Fund,
Undisclosed Investors
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 7
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Cellics Therapeutics 21-Apr-17 San Diego, CA Early Stage VC
Developer of nanosponge technology for the treatment of animal
venoms and rare diseases caused by virulent factors attacking red
blood cells. 0.06 Undisclosed Investors
Carmat (ALCAR) 21-Apr-17
Vélizy Villacoublay,
France PIPE
Designer and developer of a bio-compatible, auto-regulated artificial
heart, including right and left ventricles, designed to be as close as
possible to the human heart. Undisclosed Truffle Capital
Biodesix 21-Apr-17 Boulder, CO Later Stage VC
Developer of VeriStrat, a pretreatment serum testing tool that
provides blood-based predictive and prognostic proteomic
information to help physicians guide treatment for patients with non-
small cell lung cancer. 13.17 Undisclosed Investors
AdrenaCard 21-Apr-17 Minneapolis, MN Angel
Designer and developer of a pocket-sized medical device that helps
users inject epinephrine in their legs to control dust, sun and diet
allergies. 1.04 Undisclosed Investors
Abzena (ABZA) 21-Apr-17
Cambridge, United
Kingdom PIPE
Provider of biomedical polymers designed for therapeutic applications
focused on the improvement of protein- and peptide-based drugs. 30.84
Touchstone
Innovations,
Undisclosed Investors
Vesiflo 20-Apr-17 Redmond, WA Angel
Developer of a replaceable urinary prosthesis for female adults with
bladder drainage problems. 2.73 Undisclosed Investors
Recovery Force 20-Apr-17 Fishers, IN
PE Growth/
Expansion
Developer of an active compression and wearable product platform
that enhances the performance and recovery of athletes, consumers,
patients, and military personnel. 1.09 Undisclosed Investors
Mobile Wellness
Solutions MWS 20-Apr-17 Helsinki, Finland Early Stage VC
Developer of a healthcare platform that connects insurance companies
and progressive service providers with its members to facilitate
preventive healthcare services. 1.39 Undisclosed Investors
Microdermics 20-Apr-17 Vancouver, Canada Seed Round
Provider of a novel hollow microneedle delivery platform for the
biopharmaceutical market. 0.01
Entrepreneurship@UBC
Seed Fund K5Ventures,
Shoreline Venture
Management,
Undisclosed Investors
Fresca Medical 20-Apr-17 San Clemente, CA Later Stage VC
Developer of a respiratory device that specializes in the treatment of
patients suffering from obstructive sleeping diseases. 1.80 Undisclosed Investors
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 8
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Branchpoint
Technologies 20-Apr-17 Irvine, CA Later Stage VC
Developer of an implantable wireless intracranial pressure monitoring
device. 0.42 Undisclosed Investors
ZappRx 19-Apr-17 Boston, MA Early Stage VC
Provider of an online prescription management platform designed to
modernize, automate and streamline the specialty drug process. 0.25
Qiming Venture
Partners, SR One, GV
Synpromics 19-Apr-17
Edinburgh, United
Kingdom Later Stage VC
Developer of synthetic promoters that are optimally tailored to drive
gene expression at the desired level and specificity, enabling biological
researchers to develop new products with efficacy and safety. 6.41
Scottish Enterprise
Calculus Capital,
Undisclosed Investors
Onkos Surgical 19-Apr-17
Parsippany-Troy
Hills, NJ Early Stage VC
Developer of surgical oncology technologies, including advanced 3D
printing capabilities, limb restoration technologies and biologic
technologies. 17.60
Canaan Partners, 1315
Capital, 3D Systems
Lyndra 19-Apr-17 Watertown, MA Early Stage VC
Developer of a novel therapeutic delivery platform designed to sustain
extended drug release in oral dosage form. 23.08
Polaris Partners, Quark
Venture, GF Securities,
Yonghua Capital,
Healthlink Capital,
Partners Healthcare
Innovation, Suffolk
Equity Partners,
Undisclosed Investors
Delphinus Medical
Technologies 19-Apr-17 Novi, MI Later Stage VC
Developer of a breast ultrasound system designed to differentiate
benign from malignant masses in breast cancer cases. 8.23 Undisclosed Investors
DAMAE Medical 19-Apr-17 Paris, France Early Stage VC
Developer of an in-vivo imaging technology designed to enable
cellular-resolution imaging of the skin similar to histology without the
need for tissue excision and processing. 2.14
Kurma Partners Idinvest
Partners and News
Invest
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 9
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
NeuroTronik 18-Apr-17 Durham, NC Early Stage VC
Developer of a therapeutic technology to treat acute heart failure
syndrome. 23.10
Boston Scientific,
Hatteras Venture
Partners, Synergy Life
Science Partners, Lord
Baltimore Capital,
Mountain Group
Partners and Sovereign's
Capital
Mobidiag 18-Apr-17 Espoo, Finland
PE Growth/
Expansion
Developer of diagnostic systems designed to detect gastrointestinal
infections and multi-drug resistant organisms. 4.26
Kansalaisrahoitus,
Undisclosed Investors
Inoviem Scientific 18-Apr-17 Strasbourg, France Later Stage VC
Developer of pre-clinical and clinical technologies designed to
improve lead compound selection and decrease attrition rates during
drug development. 0.80
Capital Grand Est
Bpifrance, Strasbourg
Eurometropole
Cellesce 18-Apr-17
Cardiff, United
Kingdom
PE Growth/
Expansion
Developer of new bio-processing technology intended towards the
growth and expansion of organoids. Undisclosed Finance Wales
CanSino Biologics 18-Apr-17 Tianjin, China Later Stage VC
Developer and manufacturer of vaccine products, including four
novel vaccine candidates against Ebola, tuberculosis, cervical cancer
and pneumococcal infection and new combo vaccines against
meningitis, pertussis, tetanus, diphtheria and Hib. 0.65
SDIC Innovation
Investment
Management, Gopher
Asset, Fortune Venture
Capital, Gold Stone
Investment, Lilly Asia
Venture, Qiming
Venture Partners
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 10
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Bonti 18-Apr-17 Newport Beach, CA Early Stage VC
Developer of novel treatments for the treatment of muscle
hyperactivity, the root cause of musculoskeletal pain, in both post-
surgical and non-surgical settings. 11.71
RBV Capital, City Hill
Venture Partners, Hunt
Technology Ventures,
Colt Ventures, JMCR
Partners, HighLight
Capital, Undisclosed
Investors
Actavalon 18-Apr-17 Corona del Mar, CA Angel
Developer of a single, broad spectrum drug designed to target and
eradicate human cancer cells of all types, such as breast, lung,
pancreatic, and colon cancer. 0.03 Undisclosed Investors
VitaHEAT Medical 17-Apr-17
Rolling Meadows,
IL Angel
Provider of a patient warming technology that includes interactive
temperature sensors to actively monitor temperature. 3.69 Undisclosed Investors
RS Research 17-Apr-17 Istanbul, Turkey Early Stage VC
Provider of a novel research platform intended to develop next
generation therapeutics by developing a pioneering class of
nanocarriers that can be used in various proprietary programs in
various stages of preclinical development for the treatment of cancer. 1.28 ACT Venture Partners
Orbis Health Solutions 17-Apr-17 Greenville, SC Angel
Developer of improved methods to stimulate a patient's immune
system and enhance its ability to recognize and destroy disease entities. 0.55 Undisclosed Investors
More Health (mobile
health) 17-Apr-17 Beijing, China Early Stage VC
Developer of a healthcare management platform that integrates data
collection, data analysis, health management and behavioral
intervention into an algorithm called health behavior index that
regulates healthy behavior using a numerical value. 36.30
CITIC Capital Parnters,
Agricultural Bank of
China
Establishment Labs 17-Apr-17 Alajuela, Costa Rica Later Stage VC
Developer of breast and body shaping implants using state-of-the-art
design and manufacturing technologies. 0.18
Kilowatt Capital,
Florence Capital
Advisors
Colorado Therapeutics 17-Apr-17 Broomfield, CO Angel
Developer of xenogenic biologic tissue matrix products and
therapeutic devices for a broad range of soft tissue reinforcement,
regenerative and vascular applications. 2.57 Undisclosed Investors
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 11
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
ClariCare 17-Apr-17 Indianapolis, IN Angel Developer of cloud-based dental practice management tools. 0.36 Undisclosed Investors
Zhejiang POCTech
Medical 14-Apr-17 Huzhou, China Later Stage VC
Provider of portable medical monitoring systems consisting of high-
end biosensors to continuously monitor glucose levels. 14.51
Bioventure Investment
Management, Tasly
Great Health Industry
Fund, Tonghua
Dongbao
Pharmaceutical, Legend
Capital
NantCell 14-Apr-17 Culver City, CA Angel
Developer of immunology-based treatments and drugs for the
treatment of cancer and auto-immune diseases. 9.25 Undisclosed Investors
HealthLynked 14-Apr-17 Naples, FL Angel
Provider of a personal electronic medical records system that allows
patients to archive their medical records in coordination with their
physician. 4.02 Undisclosed Investors
Clustermarket 14-Apr-17
London, United
Kingdom Seed Round
Provider of an online marketplace intended to help life scientists list,
discover and book lab space, equipment, expertise and tissues within
their institution or cluster. Undisclosed
London Co Investment
Fund, Undisclosed
Investors
Aspect Imaging 14-Apr-17 Shoham, Israel Angel
Developer of MRI and NMR systems that offer 3D medical imaging
for medical diagnosis and other clinical purposes. 0.30
Stewart Resnick, Eri
Steimatzky
Theraworx 13-Apr-17 Asheville, NC Later Stage VC
Provider of specialty care packs for peri-care prior to foley catheter
insertion and on-going foley maintenance. 34.56 Undisclosed Investors
Sansoro Health 13-Apr-17 Minneapolis, MN Early Stage VC
Developer of Emissary, a reusable, rapidly scalable and secure API
plug-and-play solution for seamless EMR data integration. 5.25
Bain Capital Ventures,
Healthy Ventures,
Treehouse Health,
Undisclosed Investors
ProCheck 13-Apr-17 Karachi, Pakistan Angel Developer of a traceability platform created to authenticate drugs. 0.25 Sarmayacar
Oxford Heartbeat 13-Apr-17
London, United
Kingdom
Accelerator/
Incubator
Developer of a healthcare platform using predictive computations and
AI to help clinicians accurately plan and rehearse stent placements
inside blood vessels. Undisclosed Pitch@Palace
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 12
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
M3 Biotechnology 13-Apr-17 Seattle, WA Later Stage VC
Developer of therapeutics and drugs targeting large protein growth
factors for the treatment of neurodegenerative diseases, such as
Alzheimer's, Parkinson's, and ALS. 1.40
Alzheimer's Drug
Discovery Foundation,
Dolby Family Ventures
LIDDS (LIDDS) 13-Apr-17 Uppsala, Sweden PIPE Manufacturer of pharmaceutical products. 0.47 Undisclosed Investor
ILiAD Biotechnologies 13-Apr-17 New York, NY Angel Developer of an improved vaccine to prevent bordetella pertussis. 2.75 Undisclosed Investors
Gel4Med 13-Apr-17 Boston, MA Early Stage VC
Developer of an antimicrobial regenerative tissue scaffolding matrix
designed to prevent postoperative surgical site infections and
complications. Undisclosed Breakout Labs
Envisagenics 13-Apr-17 Huntington, NY Early Stage VC
Developer of a bio-data analysis platform designed to extract
biologically relevant RNA isoforms from raw RNA-seq data, enabling
scientists to detect, quantify and interpret ribonucleic acid sequencing
for reducing drug-development risks. Undisclosed Breakout Labs
EnGeneIC 13-Apr-17 Sydney, Australia Later Stage VC
Developer of a first-in-class, cyto-immunotherapy technology created
to target delivery of chemotherapeutics and functional nucleic acids in
cancer. 0.15 Undisclosed Investors
ClearDATA 13-Apr-17 Austin, TX Later Stage VC
Developer of a healthcare managed cloud platform designed to
safeguard patient's data. 0.12
Merck Global Health
Innovation Fund
Norwest Venture
Partners and Excel
Venture Management,
Heritage Group, HLM
Venture Partners, Flare
Capital Partners
BodyChillz 13-Apr-17
Gatwick, United
Kingdom
Accelerator/
Incubator
Developer, designer and distributor of a non-invasive, unpowered
medical device intended to provide rapid core body cooling to victims
of heatstroke, cardiac arrest and other conditions. Undisclosed Pitch@Palace
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 13
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Bioprotect 13-Apr-17 Kfar-Saba, Israel Later Stage VC
Developer of biodegradable balloon systems to protect the rectum
from potential risk of rectal toxicity, enabling patients to undergo
radiation therapy for prostate cancer. 3.50 Undisclosed Investors
Bioniz 13-Apr-17 Irvine, CA Later Stage VC
Developer of small peptides and molecules for treatment of
autoimmune diseases and some forms of cancer. 15.55
Takeda Ventures, David
Pyott, Cota Capital, Joe
Kiani, Undisclosed
Investors
BFKW 13-Apr-17 Grand Rapids, MI Angel
Developer of implanted bariatric devices designed to treat obesity by
inducing long lasting satiety. 2.10 Undisclosed Investors
ALung 13-Apr-17 Pittsburgh, PA Later Stage VC
Provider of advanced medical devices to treat respiratory disorders.
The company engages in the development and sale of intra and extra
corporeal gas exchange device used for the treatment of respiratory
failure. 36.56
Philips and UPMC
Enterprises, Abiomed,
Hermes Group, Allos
Ventures, Birchmere
Ventures, Blue Tree
Ventures, Riverfront
Ventures, Undisclosed
Investors
Adaptive Phage
Therapeutics 13-Apr-17 Bethesda, MD Seed Round
Provider of therapeutics services intended to treat multi-drug resistant
pathogenic bacteria. 0.77 Undisclosed Investors
SYNLAB International 12-Apr-17 Munich, Germany
PE Growth/
Expansion
Provider of medical laboratory services in various diagnostics fields,
including human medical laboratory medicine, human genetics, and
preventive health care. 267.21 Novo Group
Protein Dynamic
Solutions 12-Apr-17 Mayagüez, PR Angel
Provider of clinical trials and biotechnology research and developer of
tools for testing anti-malignant drugs for cancer treatments. 0.02 Undisclosed Investors
HiberGene Diagnostics 12-Apr-17 Dublin, Ireland Later Stage VC
Developer of real-time molecular diagnostic technology designed to
test human infectious diseases. 7.16
Cantor Fitzgerald,
Kernel Capital,
MedCaptain
eXo Systems 12-Apr-17 Oakland, CA Early Stage VC Provider of ultrasound medical imaging technology. 6.05 Undisclosed Investors
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 14
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
DesignMedix 12-Apr-17 Portland, OR Later Stage VC
Developer of drugs to combat drug-resistant diseases, such as malaria,
bacterial diseases, sexually transmitted diseases, and other infectious
diseases. 0.65 Undisclosed Investors
Botanix Pharma (BOT) 12-Apr-17 Subiaco, Australia PIPE
Developer of therapeutics for serious skin diseases utilizing synthetic
cannabidiol to improve the lives of patients battling acne, psoriasis and
atopic dermatitis. 4.12 Undisclosed Investors
The Eye Machine 11-Apr-17 Indian Wells, CA Angel
Manufacturer of a medical device that condenses current from direct
current barriers in order to deliver energy around the eye, mitigating
the effects of age-related macular degeneration and diabetic
retinopathy 1.91 Undisclosed Investors
TargEDys 11-Apr-17 Rouen, France Later Stage VC
Developer of hormone mimetic proteins that help in regulating the
eating behavior of obese people. 11.12
Seventure Partners
Pontifax, NCI, Zaluvida,
Bpifrance and NCI
Gestion
Smart Reporting 11-Apr-17 Munich, Germany Early Stage VC
Developer and provider of a structured medical reporting platform
designed to help doctors to increase the quality of their medical
reports. 2.14
Cascara Ventures,
Investment and
Structural Bank of
Rhineland-Palatinate,
Sparkassen-Innovations-
Beteiligungsfinanzierung
sgesellschaft Rheinland-
Pfalz, Undisclosed
Investors
SA Ignite 11-Apr-17 Chicago, IL Later Stage VC
Provider of a cloud-based platform designed to simplify and automate
complex quality reporting, leverage proactive insights to improve
performance, achieve regulatory compliance and satisfy quality
metrics. 2.05 Undisclosed Investors
RC21X 11-Apr-17 Coraopolis, PA
Accelerator/
Incubator
Developer of a web-based measurement and monitoring system
designed to monitor human brain performance. 0.10 Stadia Ventures
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 15
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Frequency Therapeutics 11-Apr-17 Woburn, MA Early Stage VC
Developer of small molecule drugs intended to activate progenitor
cells within the body to restore and regenerate sensory cells in the
inner ear to treat chronic noise-induced hearing loss. 0.32
Cobro Ventures,
Alexandria Real Estate
Equities, Emigrant
Capital, Korea
Investment Partners,
Morningside Group
CoreRx 11-Apr-17 Clearwater, FL
PE Growth/
Expansion
Developer and manufacturer of complex oral drugs designed to help
speed the development of drug candidates. 0.05 Undisclosed Investors
BlueprintBio 11-Apr-17 Newport Beach, CA Early Stage VC
Provider of pharmaceutical services that identifies, protects and offers
new biological discoveries to existing clinical, pharmaceutical and
diagnostic companies for personalized medicine treatment. 0.48 Undisclosed Investors
biOasis Technologies
(BTI) 11-Apr-17 Richmond, Canada PIPE
Developer of a platform that delivers therapeutic compounds across
the blood-brain barrier and into the central nervous system for the
treatment of neurological diseases, including brain cancers,
neurodegenerative diseases and metabolic disorders. 3.03 Undisclosed Investors
Synchrony Health 10-Apr-17 Louisville, KY Angel
Provider of healthcare data management and advisory services
intended to build accountable care organizations. 0.10 Undisclosed Investors
Lybrate 10-Apr-17 Faridabad, India Early Stage VC
Developer of an online doctor consultation platform designed to allow
patients access to medical professionals 24 hours a day, 7 days a week,
and help doctors effortlessly manage and grow their practice. 0.03 Undisclosed Investors
ESO Solutions 10-Apr-17 Austin, TX Later Stage VC
Provider of electronic patient care reporting software and billing
services that enable users to share patient data in a bi-directional and
vendor-agnostic environment for fire departments, ambulance billing
operations and others. 0.01
Wild Basin Investments,
Undisclosed Investors
Esanex 10-Apr-17 Indianapolis, IN Later Stage VC
Developer of highly selective and orally active Hsp90 inhibitors for
the treatment of cancer. 2.58 Undisclosed Investors
EnXray 10-Apr-17
Liverpool, United
Kingdom Early Stage VC
Developer of radiation sterilization equipment for generation of low
energy X-rays. 3.86
The North West Fund,
CBC Holdings
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 16
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Cirius Therapeutics 10-Apr-17 Kalamazoo, MI Early Stage VC
Developer of an insulin sensitizer designed for the treatment of
nonalcoholic steatohepatitis. 0.40
Frazier Healthcare Novo
A S, Adams Street
Partners, Hopen Life
Science Ventures,
Renaissance Venture
Capital Fund
Geom Therapeutics 8-Apr-17 San Diego, CA Early Stage VC
Developer of novel antibiotics created to provide broad spectrum
coverage including activity against multi-drug resistant Pseudomonas
and Acinetobacter. 4.36
Sears Capital
Management,
Undisclosed Investors
Vasoptic Medical 7-Apr-17 Baltimore, MD Angel
Developer of a portable retinal imager designed to non-invasively
capture physiological information from the retinal microvasculature,
providing a quantitative means of monitoring the progression of
various metrics indicative of ophthalmic and systemic disease. 1.55 Undisclosed Investors
Sonomotion 7-Apr-17 San Francisco, CA Angel
Developer of a non-invasive medical device for kidney stone
treatment. 4.50 Undisclosed Investors
Small Pharma 7-Apr-17
London, United
Kingdom Angel
Developer of antidepressant drugs based on a derivative of ketamine
that can inject antibiotics in limited quantity to activate cerebral
stimulus as per patient's mental and physical fitness. 1.02
Chris Torrance David
Ebsworth Peter Keenn
Steve Harris
SyndicateRoom, Tom
Valentine
OptiNose 7-Apr-17 Yardley, PA Later Stage VC
Developer of exhalation delivery systems that produce high and deep
intranasal deposition of medication. 0.35 Undisclosed Investors
Nanobiotix (NANO) 7-Apr-17 Paris, France PIPE
A nanomedicine company pioneering novel approaches for the local
treatment of cancer by magnifying the effect of radiotherapy within
tumor cells without increasing the dose to surrounding healthy tissues. 26.88
Capital Ventures
International, CM-CIC
Investissement,
Bpifrance, Undisclosed
Investors
MyPostOpCare 7-Apr-17 Huntsville, AL Angel
Developer of an application that offers post-surgery instructions and
guidance to patients to help them in the recovery process. 0.23 Undisclosed Investors
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 17
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
ID Genomics 7-Apr-17 Seattle, WA Angel
Developer of a genomics bar-coding-based diagnostic system used to
identify and track drug-resistant human pathogens. 0.68 Undisclosed Investors
Chinova Bioworks 7-Apr-17 Fredericton, Canada
Accelerator/
Incubator
Developer of a antimicrobial chitosan polymer designed to enhance
the shelf-life of medical products, such as cell cultures and liquid
pharmaceuticals. Undisclosed Terra Accelerator
Abpro 7-Apr-17 Woburn, MA Later Stage VC
Provider of protein reagents and services and developer of a discovery
platform for research purposes, such as diagnostics and therapeutics,
that streamlines all aspects of the process to deliver antibodies. 0.10 Undisclosed Investors
Sommetrics 6-Apr-17 Vista, CA Later Stage VC
Developer of medical products and services using proprietary aer+
technology to develop tools for disorders related to the narrowing of
the airway during sleep, such as obstructive sleep apnea and chronic
snoring. 12.30 Undisclosed Investors
Ortho Kinematics 6-Apr-17 Austin, TX Later Stage VC
Provider of a diagnostic test for the spine that uses fluoroscopy to
capture the spine in motion and produces patient-specific graphs that
are uploaded to cloud servers where they are processed to produce
motion measurements for each vertebral level. 20.72
TEXO Ventures Wild
Basin Investments and
Central Texas Angel
Network, Undisclosed
Investors
OM1 6-Apr-17 Cambridge, MA Early Stage VC
Provider of a platform system that gathers, synthesizes, enriches, and
leverages clinical data to provide measurements and AI-driven insights
and predictions that can improve clinical, financial and operational
management. 0.15
General Catalyst
Partners, Glikvest, 7wire
Ventures, Wanxiang
Healthcare Investments
Novita Pharmaceuticals 6-Apr-17 New York, NY Angel Developer of therapeutic drugs for the treatment of cancer. 6.46 Undisclosed Investors
MGB Biopharma 6-Apr-17
Glasgow, United
Kingdom Later Stage VC
Developer of antibiotics intended to offer a new class of anti-infective
medicine. The company's antibiotics offers a new class of small
molecules, with specific antibacterial activity against susceptible and
resistant bacteria, enabling clients to treat bacterial infections through
antibiotics based on Minor Groove Binder (MGBs) compounds. 1.15
Archangel Informal
Investors, TRI Cap,
Barwell and Scottish
Enterprise
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 18
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
LB Pharmaceuticals 6-Apr-17 New York, NY Angel Operator of a drug development company. 1.43 Undisclosed Investors
InnerSpace Neuro
Solutions 6-Apr-17 Tustin, CA Angel Developer of an intracranial pressure monitoring technology system. 2.78 Undisclosed Investors
drchrono 6-Apr-17 Mountain View, CA Later Stage VC
Provider of an electronic health record platform designed to offer
patient health insurance verification and medical billing services. 0.14
Runa Capital, Maxfield
Capital, Team in
Residence, SVB Capital,
Box, FundersClub, Eric
Dunn, Bruno Bowden
Darwin Life 6-Apr-17 New York, NY Angel
Developer of an in vitro fertilization technology created to reverse the
effects of age on human oocytes and repair certain cellular defects. 0.01 Undisclosed Investors
Biomarker.io 6-Apr-17 San Francisco, CA
Accelerator/
Incubator
Developer of an online health platform designed to track and decode
impact of dietary changes on health and performance. Undisclosed Terra Accelerator
Alliance Growers
(ACG) 6-Apr-17 Vancouver, Canada PIPE Producer of medical marijuana. 0.05 Alumina Partners
HealthFeed (Velocitos) 5-Apr-17 Sunnyvale, CA Angel
Provider of an automated content delivery platform designed for
healthcare patients and members. 0.01 Undisclosed Investors
Contraline 5-Apr-17 Charlottesville, VA Seed Round
Developer of non-hormonal, non-surgical and reversible male
contraceptive technology. 2.50
Founders Fund,
Abstract Ventures,
Jaffray Woodriff, Center
for Innovative
Technology, Jason
Calacanis, Afton
Scientific
Axial3D 5-Apr-17
Belfast, United
Kingdom Seed Round
Developer of a patient-specific 3D printed model designed to better
understand a patient's unique pathology and deliver personalized
anatomical insights. 0.65
Techstart NI, Patrick
Hurst, Undisclosed
Investors
Acera 5-Apr-17 Owings, MD Angel
Manufacturer of endoscopic brushes designed to fill unmet needs in
the field of gastrointestinal endoscopy. 0.03 Undisclosed Investors
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 19
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Viracta Therapeutics 4-Apr-17 San Diego, CA Later Stage VC
Operator of a clinical-stage drug development company intended to
develop medicines to treat virus-associated cancers. 18.40
NantKwest, Wicklow
Capital, Latterell
Venture Partners,
Forward Ventures
Synchron 4-Apr-17 Campbell, CA Later Stage VC
Developer of a minimally invasive implantable device designed to
interpret signals from the brain for the treatment of brain pathologies,
such as paralysis, epilepsy and movement disorders. 0.10
NeuroTechnology
Investors, Defense
Advanced Research
Projects Agency, United
States Department of
Defense
Sentien Biotechnologies 4-Apr-17 Lexington, MA Later Stage VC
Developer of new blood conditioning therapies harnessing the power
of cell therapy with innovative drug delivery systems designed to
restore balance to the immune system of critically ill patients. 0.12
Boehringer Ingelheim
Venture Fund,
BioInnovation, Chiesi
Ventures, MBL Venture
Capital, Mass Medical
Angels
Prevent Biometrics 4-Apr-17 Minneapolis, MN Early Stage VC
Developer of a real-time head impact monitoring system designed to
record the force, location and direction of head impact, enabling
coaches, trainers and parents to instantly know when an athlete is hit
hard enough to cause a concussion. 3.80 Undisclosed Investors
PEC360 4-Apr-17
North Charleston,
SC Later Stage VC
Provider of a patient management platform designed to proactively
identify, manage and schedule patients with healthcare needs. 0.20
SCRA Technology
Ventures
Nova Satra Diagnostics 4-Apr-17
Singapore,
Singapore Angel
Developer of blood-based diagnostic tests that leverage epigenetic
platform technology for testing breast cancer using stable DNA-based
targets as part of chromosomal signatures to allow healthcare
providers to accurately diagnose and detect cancer at earlier stages. 1.99 Genting Bio Cellular
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 20
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Neural Analytics 4-Apr-17 Los Angeles, CA Early Stage VC
Manufacturer of medical devices for measuring intracranial pressure
designed to accurately assess mild to traumatic brain injury, including
concussions. 10.15
Reimagined Ventures,
Undisclosed Investors
Micell Technologies 4-Apr-17 Durham, NC Later Stage VC
Developer of drug-delivery systems for cardiovascular diseases
designed to limit the duration of polymer exposure, optimize healing,
more precisely and consistently control drug elution, and improve
safety and clinical outcomes. 31.78 Undisclosed Investors
Lakewood-Amedex 4-Apr-17 Sarasota, FL Angel
Developer of an oligonucleotide gene-silencing platform designed to
treat infectious diseases, such as hepatitis B and C, pandemic viral
infections and avian influenza. 2.90 Undisclosed Investors
Innovative
Cardiovascular
Solutions 4-Apr-17 Grand Rapids, MI Angel
Developer of an embolic protection catheter that has been designed to
be utilized in trans aortic valve replacement procedures and other left
heart interventional procedures. 3.09 Undisclosed Investors
GLG Pharma (GLG) 4-Apr-17 Wroclaw, Poland PIPE
Developer of advanced cancer therapy techniques based on STAT3
protein for the treatment of tumors, lung cancer, leukemia and other
hyperproliferative diseases. Undisclosed
Apollo Global
Management
Deutsche Arzt 4-Apr-17 Essen, Germany Early Stage VC
Developer of an e-health platform designed to connect doctors,
patients, physiotherapists and health insurance funds online. Undisclosed
NRW.Bank, Optadata,
Novinvest
AbCellera 4-Apr-17 Vancouver, Canada Later Stage VC
Developer of a microfluidic single-cell platform that screens millions
of immune cells in a single day, increasing the speed and efficiency of
monoclonal antibody discovery with the potential to accelerate the
development of urgently needed diagnostic tests and vaccines. 0.82 Undisclosed Investors
Transplant Genomics 3-Apr-17 Mansfield, MA Early Stage VC
Developer of molecular diagnostic tests to improve organ transplant
outcomes with non-invasive serial monitoring guided by genomics. 8.05 Undisclosed Investors
The Progressive
Orthopaedic Company 3-Apr-17
North Palm Beach,
FL
PE Growth/
Expansion
Manufacturer and distributor of low-cost orthopaedic implants and
medical devices. Undisclosed IBS Investment Bank
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 21
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Simple Contacts 3-Apr-17 New York, NY Early Stage VC
Developer of a mobile application designed to test and renew eyewear
prescriptions. 0.08
Goodwater Capital,
Justin Kan, Notation
Capital, Autonomous
Ventures, Steven Cohen,
Undisclosed Investors
RxSight 3-Apr-17 Aliso Viejo, CA Later Stage VC
Developer of adjustable intraocular technology designed to empower
the global cataract market and transform cataract surgery from a
purely predictive method to a dynamic prescription process. 48.98 Undisclosed Investors
Redox 3-Apr-17 Madison, WI Early Stage VC
Provider of an information technology platform designed to eradicate
technical barriers in healthcare systems. The company's information
technology platform can be integrated with EHRs and health systems
enabling digital healthcare enterprises to manage their connections in
the cloud. 0.10
RRE Ventures, .406
Ventures, Flybridge
Capital Partners,
Dreamit Ventures,
HealthX Ventures,
Intermountain
Healthcare
Opthea (OPT) 3-Apr-17
South Yarra,
Australia PIPE
Developer of novel biologic therapies to block vascular growth factors
that cause blood vessels to leak and lead to eye diseases. 32.01 Undisclosed Investors
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 22
Monthly Healthcare Review
April 2017
Company Name
Last
Financing
Date
HQ Location Round Description
Last
Financing
Size
(Millions)
Investor(s)
Private Equity Placements and Venture Capital RoundsThe following table includes institutionally placed private equity financings for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced
over the previous month.
Intarcia Therapeutics 3-Apr-17 Boston, MA Later Stage VC
Developer of therapeutic products to enhance treatment outcomes by
optimizing and improving the efficacy, continuous administration and
tolerability of drug therapies. 475.68
Kayon Partners, Baillie
Gifford, Bill & Melinda
Gates Foundation,
Luxin Venture Capital,
Fidelity Investments, RA
Capital Management,
Foresite Capital
Management, The
Pritzker Organization,
The Baupost Group,
Undisclosed Investors
Chartfill 3-Apr-17 Victor, NY Angel
Provider of a clinical data analytics platform designed to streamline
care transitions and enhance patient satisfaction. 0.23 Undisclosed Investors
Analytics 4 Life 3-Apr-17 Kingston, Canada Angel
Developer of a cardiac monitoring device using advanced signal
processing techniques and machine-learned algorithms to reveal
previously hidden information about a patient's health status from
within their physiological signals in the coronary artery. 4.09 Undisclosed Investors
HUMM Technologies 2-Apr-17 Perth, Australia
Accelerator/
Incubator
Developer of a neurotechnology product that allows to see the
workings of the brain, guides in behavioral changes, and harnesses
recent advances in machine learning, cloud processing and wearable
technology, supplementing human intelligence with artificial
intelligence. 0.03 Plus Eight Accelerator
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 23
Monthly Healthcare Review
April 2017
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Allergan Zeltiq Aesthetics Pleasanton, CA 28-Apr-17
Developer of a non-surgical fat reduction treatment that uses controlled cooling
to eliminate fat without affecting surrounding tissue. 24.80
Numotion
Horn's Medical
Supply Athens, TX 28-Apr-17
Developer of power wheelchairs, pediatric equipment, beds and accessories,
oxygen therapy and other mobility products. Undisclosed
Savara Pharmaceuticals Mast Therapeutics San Diego, CA 27-Apr-17
Developer of novel, clinical-stage therapies for respiratory diseases, sickle cell, rare
genetic disorders, and heart failure. 1.65
DocuTap Clockwise.MD Atlanta, GA 27-Apr-17 Provider of online self-scheduling and queue management services. Undisclosed
Surgical Information
Systems
Source Medical
Solutions Birmingham, AL 25-Apr-17 Provider of ambulatory surgery center software and services. Undisclosed
Belluscura
Nanotether
Discovery Science
Cardiff, United
Kingdom 25-Apr-17
Developer of high throughput quantitative binding assays that utilize variable
length DNA molecules as tethers for binding pairs of test molecules in close
proximity, thereby miniaturising biological assays and vastly reducing the quantity
of materials required compared with current technologies. 0.33
Norgesplaster ScanSport Vennesla, Norway 24-Apr-17 Manufacturer of sports injury prevention equipment. Undisclosed
Perspective
Technologies Nanosensors Redwood City, CA 21-Apr-17
Manufacturer of sensors and semiconductor components created to detect
specified levels of targeted specific biological, chemical and explosive agents. Undisclosed
Beaver Visitec
International Malosa Medical
Halifax, United
Kingdom 21-Apr-17
Manufacturer and supplier of single-use surgical instruments for use in some of
the most frequently performed procedures, including cataract surgery and
intravitreal injection. Undisclosed
Underwriters
Laboratories Emergo Group Austin, TX 21-Apr-17
Provider of regulatory and market access services, including medical device
registration and approval, regulatory strategy, and ISO 13485 and QMS
compliance. Undisclosed
Veritas Pharma
Cannevert
Therapeutics Vancouver, Canada 21-Apr-17
Provider of cannabis strains intended to shed light on the medical potential of
cannabis by establishing a sound scientific basis for its therapeutic use research. 1.50
Protek Rafarma antibiotics Moscow, Russia 20-Apr-17
Producer and distributor of antibodies, pharmaceutical substances, anti-tumor
drugs, anti-TB drugs and other pharmaceutical related drugs. 1.00
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 24
Monthly Healthcare Review
April 2017
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
Avantor Performance
Materials Puritan Products Bethlehem, PA 20-Apr-17
Manufacturer of chemicals and custom-blended formulations intended to be used
in pharmaceutical, biotechnology, microelectronic and laboratory markets. Undisclosed
Vyaire Medical Ciel Medical San Carlos, CA 20-Apr-17 Developer of a medical device intended to treat ventilator-associated pneumonia. Undisclosed
Diploma Abacus ALS Waterford, Australia 20-Apr-17
Distributor of in vitro diagnostic products, diagnostic pathology products,
healthcare educational supplies, innovative laboratory equipment and other
diagnostics instrumentation and consumables. 11.97
PLx Pharma
Dipexium
Pharmaceuticals New York, NY 19-Apr-17
Developer of pharmaceutical products for the treatment of certain mild and
moderate skin infections in superficial wounds. Undisclosed
Heidelberg Engineering
Medisoft (Medical
Records Systems)
Leeds, United
Kingdom 18-Apr-17 Developer of electronic medical records software for the ophthalmic market. Undisclosed
Hms Holdings Eliza Danvers, MA 18-Apr-17
Designer of an integrated healthcare communication and management software
using cloud technology, advanced proprietary predictive analytics, behavioral
science and data driven design methodologies to personalize outreach. 1.72
Ciox Health ArroHealth Hauppauge, NY 18-Apr-17
Provider of analytics, medical record retrieval, data aggregation and risk
adjustment coding to accurately represent the impact of risk adjustment and
HEDIS programs and improve insights into quality metrics. Undisclosed
NextGen Healthcare
Information Systems Entrada Brentwood, TN 14-Apr-17
Developer of software for the automation of clinical documentation and data
exchanges in ambulatory clinics, surgery centers and hospitals. 0.34
Amendia Spinal Elements Carlsbad, CA 13-Apr-17
Designer and developer of spinal surgical devices designed to advance the
performance of spinal implants and instruments. Undisclosed
NantOmics Genos Research San Francisco, CA 13-Apr-17
Provider of a genomics research and discovery platform intended to accelerate
disease research and medical cures. Undisclosed
Relias Learning
Care Management
Technologies Morrisville, NC 13-Apr-17
Operator of a population health management company with deep expertise in
behavioral health data analytics intended to deliver actionable information to
clinicians at the point of treatment to improve quality of care and reduce costs. Undisclosed
Group Doehler HIS (France) Lyon, France 12-Apr-17
Provider of health ingredients for the dietary supplement, food and beverage,
nutrition, cosmetic and pharmaceutical industries. Undisclosed
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 25
Monthly Healthcare Review
April 2017
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
Exova SL Pharma Labs Wilmington, DE 11-Apr-17
Provider of parenteral, liquid and topical drug products including formulation
development, analytical development, microbiological development and early stage
clinical manufacturing. Undisclosed
Anju Software OpenQ Charlottesville, VA 11-Apr-17
Developer of software applications that combine big data and expert validation to
deliver actionable information that mitigates compliance risks. Undisclosed
MYM Nutraceuticals HempMed Toronto, Canada 11-Apr-17
Developer and marketer of Hemp CBD extract and oil infused nutraceutical
products. 0.01
GE Healthcare Asymptote
Cambridge, United
Kingdom 11-Apr-17
Developer of cryochain technology designed to maintain the potency of cellular
therapies by enabling ultra-low temperature freezing during production all the way
to thawing at the clinic prior to administering to patients.. Undisclosed
Alexander Zharkov TNK Silm Moscow, Russia 10-Apr-17
Developer of silicone compound-based drugs for atopic dermatitis, psoriasis,
diarrhea of various origins, food poisoning, hangovers, eczema, and acne. Undisclosed
DePuy Synthes Neuravi Galway, Ireland 10-Apr-17
Developer of innovative medical devices designed for neurointerventional
therapies. Undisclosed
PetVivo
Gel-Del
Technologies Saint Paul, MN 10-Apr-17
Manufacturer of bio-material devices, including cosmetic tissue fillers, blood
vessel grafts, implanted oral and drug delivery systems. 0.40
Mr Rene Lauritsen
Alterola Biotech
(nutraceutrical
chewing gum
business) Walnut, CA 10-Apr-17
Manufacturer of nutraceutrical chewing gum used as an appetite and cholesterol
suppressor, as well as for motion sickness control. Undisclosed
Jordan Industries
International
Transtate
Equipment
Company Charlotte, NC 7-Apr-17
Provider of refurbished catheter angiography equipment along with on-site
services. Undisclosed
VWR International Mesm
Chorley, United
Kingdom 7-Apr-17
Manufacturer and supplier of laboratory and medical equipment and ancillary
supplies, including analyzers, spirometers, freezers, measuring devices and
infusion and syringe pumps. Undisclosed
Alpha Source Medical Optics Tamarac, FL 7-Apr-17
Provider of a medical instrument repair management tool designed to repair and
keep records of medical equipment. Undisclosed
Grünenthal Adhesys Medical Aachen, Germany 7-Apr-17
Developer and manufacturer of next generation surgical adhesives created to
bring novel surgical sealants to physicians. Undisclosed
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 26
Monthly Healthcare Review
April 2017
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
Valens GroWorks Supra Thc Services Kelowna, Canada 6-Apr-17
Provider of microbial screening, analysis, testing and development for medical
marijuana. 3.75
Touchstone
Innovations
Cardian
(Monitoring
Equipment)
London, United
Kingdom 6-Apr-17
Provider of wireless pulmonary arterial pressure sensor device intended to
improve the monitoring and treatment of cardiac failure patients. 1.85
Medical Imaging
Partnership
Medical Imaging
London
London, United
Kingdom 5-Apr-17 Provider of diagnostic imaging and reporting services. Undisclosed
Cannabis Science Jinvator BioMed
Bad Honnef,
Germany 5-Apr-17 Developer of a rapid HIV/AIDS test. Undisclosed
Porvair
J. G. Finneran
Associates Vineland, NJ 5-Apr-17
Manufacturer and distributor of specialist laboratory products intended to offer
custom designed machinery and accessories, including filters, vials, microplates,
closures and ancillary products. 0.14
iHealth Innovations emPower Docs New York, NY 5-Apr-17
Provider of healthcare software products and related services to large independent
practices that specialize in vascular surgery, cardiology, orthopedics, and several
primary care specialties. Undisclosed
Concordance
Healthcare Solutions
Rockwell Medical
Supply Seal Beach, CA 4-Apr-17
Supplier of medical products, including cotton balls, exam tables, diagnostic lights,
tongue depressors, ECG equipment, spirometry equipment and disposable items. Undisclosed
Mitchell International PMOA Mobile, AL 4-Apr-17
Operator of a pharmacy benefit management company created to offer simplified
cost-control services. Undisclosed
Teletech Holdings Connextions Orlando, FL 4-Apr-17
Developer of a proprietary technology-enabled services platform designed to offer
member acquisition, retention and engagement services. 0.80
CareFusion
Caesarea Medical
Electronics Caesarea, Israel 4-Apr-17
Manufacturer of medical infusion and syringe pump systems designed to offer
project level customization including specialist disposables, software language
adaptation and other treatment solving services. Undisclosed
Sucampo
Pharmaceuticals Vtesse Gaithersburg, MD 3-Apr-17
Developer of new drug treatments designed to treat severe and life-threatening
lysosomal storage diseases. 2.00
Wellpass Voxiva Arlington, VA 3-Apr-17
Provider of an online member engagement platform created to communicate
about health programs. Undisclosed
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 27
Monthly Healthcare Review
April 2017
Acquirer Target HQ Location Date DescriptionTransaction
Value (Millions)
Mergers and AcquisitionsThe following table includes mergers and acquisitions for private and public medical devices, biotechnology, pharmaceuticals, and healthcare companies announced over the previous
month.
Nordson
Vention Medical
(Advanced
Technologies
Business) Salem, NH 3-Apr-17
Designer, developer and manufacturer of minimally invasive interventional
delivery devices, catheters and advanced components. 7.05
Aurora Diagnostics
University
Pathologists Warwick, RI 3-Apr-17 Provider of hospital-based professional anatomic pathology services. Undisclosed
Mr Ian Aaron and other
undisclosed investors UK Medical
Sheffield, United
Kingdom 3-Apr-17
Supplier of interventional medical devices used in minimally-invasive image-
guided procedures to diagnose and treat diseases in various organs of the body,
with a particular focus on devices used in breast radiology, urology, interventional
radiology and cardiology. Undisclosed
Teleflex Pyng Medical Richmond, Canada 3-Apr-17
Developer of medical technology for critical-care environments created to
commercialize trauma and resuscitation products. 8.60
Castlight Health Jiff Mountain View, CA 3-Apr-17 Developer of a cloud-based application platform to manage patients. Undisclosed
Dynatronics
Hausmann
Industries Northvale, NJ 3-Apr-17
Manufacturer of a full range of laminate treatment tables, stools, benches and
cabinets along with medical, therapy and athletic training equipment. 0.10
McKesson
GMD
PharmaSolutions Oakville, Canada 3-Apr-17
Provider of pharmaceutical logistic services intended to offer direct distribution
and point-of-care administration of specialty pharmaceuticals. Undisclosed
Sartorius Essen BioScience Ann Arbor, MI 3-Apr-17
Developer and manufacturer of instruments, software, reagents and consumables
that allow researchers to remotely image and quantitate a wide variety of cellular
processes over time. 3.20
Svenska Cellulosa
Aktiebolaget BSN medical Luxembourg 3-Apr-17
Provider of casting, bandaging, and compression stockings for wound care and
vascular diseases. 1496.40
Sirius International
Insurance Group ArmadaGlobal Hunt Valley, MD 3-Apr-17
Provider of employee benefit consulting services created to fill the growing
financial and accessibility gaps in the healthcare system. Undisclosed
Wellpartner
340B SMART
Solutions Memphis, TN 3-Apr-17 Provider of split-billing and retail pharmacy gateway software. Undisclosed
The Carlyle Group WellDyneRx Lakeland, FL 1-Apr-17
Provider full-service prescription drug management between patients and drug
plans through a network of retail providers in addition to a mail order and
specialty drug pharmacy. Undisclosed
Compiled by: Lea Keller and Morgan Reape
Source: Pitchbook 28